Abstract
Cancer is a complex group of diseases where different signaling pathways have been found to be deregulated, mainly related to cell proliferation, angiogenesis, metastasis, evasion of apoptosis and insensitivity to anti-growth sings among others. Diet plays a fundamental role in the treatment of the oncological patients, we must be aware that food can interact with certain types of cancer therapy. On the other hand, cancer therapies sometimes affect the patient’s sense of smell, taste, appetite, gastric capacity or nutrient absorption, which often results in malnutrition due to the lack of essential nutriments. In this chapter we will review the effect of different metabolic disorders in cancer and mechanisms of action of some phytochemicals found in different foods like resveratrol, EGCG, curcumin and lycopene.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108
Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C (2017) Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer 69(8):1151–1176
Renehan AG, Soerjomataram I (2016) Obesity as an avoidable cause of cancer (attributable risks). Recent Results Cancer Res 208:243–256
Lyengar NM, Gucalp A, Dannenberg AJ, Hudis CA (2016) Obesity and Cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 34(35):4270–4276. https://doi.org/10.1200/JCO.2016.67.4283
Dutta D, Ghosh S, Pandit K, Mukhopadhyay P, Chowdhury S Leptin and cancer: pathogenesis and modulation. Indian J Endocrinol Metab 16(Suppl 3):S596–S600
Wu Y, Zhang D, Kang S (2013) Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat 137(3):869–882
Khan S, Shukla S, Sinha S, Meeran SM (2013) Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev 24(6):503–513
Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD et al (2015) Circulating adipokines and inflammatory markers and postmenopausal breast cancer risk. J Natl Cancer Inst 107(9):djv169
Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Bustos M, Martínez JA, Moreno-Aliaga MJ (2011) Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta Bioenerg 1807(6):664–678
Khatib SA, Rossi EL, Bowers LW, Hursting SD (2016) Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids. Prostaglandins Other Lipid Mediat 125:100–107
Van Kruijsdijk RC, van der Wall E, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18(10):2569–2578
Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK et al (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19(9):2381–2389
Hopkins BD, Goncalves MD, Cantley LC (2016) Obesity and cancer mechanisms: Cancer metabolism. J Clin Oncol 34(35):4277–4283
Srikanthan P, Hevener AL, Karlamangla AS (2010) Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and nutrition examination survey III. PLoS One 5(5):e10805
Carneiro IP, Mazurak VC, Prado CM (2016) Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep 18(10):62
Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MP et al (2017) Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric Cancer. J Gastrointest Cancer 17(1):74–87
Argilés JM, Busquets S, Stemmler B, López-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14(11):754
Mendes MCS, Pimentel GD, Costa FO, Carvalheira JB (2015) Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol 226(3):R29–R43
Inácio Pinto N, Carnier J, Oyama LM, Otoch JP, Alcântara PS, Tokeshi F et al (2015) Cancer as a proinflammatory environment: metastasis and cachexia. Mediat Inflamm 2015:791060
Trayhurn P (2014) Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity. Annu Rev Nutr 34:207–236
Shivappa N, Hébert JR, Rietzschel ER, De Buyzere ML, Langlois M, Debruyne E et al (2015) Associations between dietary inflammatory index and inflammatory markers in the Asklepios study. Br J Nutr 113(4):665–671
Turner DP (2015) Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity. Cancer Res 75(10):1925–1929. https://doi.org/10.1158/0008-5472.CAN-15-0169
Jiao L, Stolzenberg-Solomon R, Zimmerman TP, Duan Z, Chen L, Kahle L, Risch A et al (2015) Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP diet and health study. Am J Clin Nutr 101(1):126–134
Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R et al (2010) Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110(6):911–916. e12
Abdelmagid SA, MacKinnon JL, Janssen SM, Ma DW (2016) Role of n-3 polyunsaturated fatty acids and exercise in breast cancer prevention: identifying common targets. Nutr Metab Insights 9:71–84
Molfino A, Amabile MI, Monti M, Arcieri S, Rossi Fanelli F, Muscaritoli M (2016) The role of docosahexaenoic acid (dha) in the control of obesity and metabolic derangements in breast cancer. Int J Mol Sci 17(4):505
Azrad M, Turgeon C, Demark-Wahnefried W (2013) Current evidence linking polyunsaturated fatty acids with Cancer risk and progression. Front Oncol 3:224
Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S (2010) Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res 49(1):76–86
Fabian CJ, Kimler BF (2013) Marine-derived omega-3 fatty acids: fishing for clues for cancer prevention. Am Soc Clin Oncol Educ Book 33:97–101
Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224(3):274–283
Aggrawal B, Bhardwaj A, Aggrawal R, Seeram NP, Hishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783–2840
Kala R, Shah HN, Martin SL, Tollefsbol TO (2015) Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer. BMC Cancer 15:672. https://doi.org/10.1186/s12885-015-1693-z
Jin W, Chen L, Chen Y, Xu S, Di G, Yin W et al (2010) UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat 123:359–373. https://doi.org/10.1007/s10549-009-0652-2
Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B et al (2011) Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases—safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res 4(9):1419–1425. https://doi.org/10.1158/1940-6207.CAPR-11-0148
Schuurman AG, Goldbohm RA, Brants HA, van den Brandt PA (2002) A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 13:573–582
Mascio P, Kaiser S, Sies H (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 274(2):532–538
Velmurugan B, Bhuvaneswari V, Nagini S (2002) Antiperoxidative effects of lycopene during N-methyl-N-nitro-N-nitrosoguanidine-induced gastric carcinogenesis. Fitoterapia 73(7):604–611
Folli F, Bonfanti L, Renard E, Kahn C, Merighi A (1994) Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 14(11):6412–6422
Raiten DJ, Ashour FAS, Ross AC, Meydani SN, Dawson HD, Stephensen CB (2015) Inflammation and nutritional science for programs/policies and interpretation of research evidence (INSPIRE). J Nutr 145(5):1039S–1108S
Chen A, Xu J, Johnson AC (2006) Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25(2):278–287
Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S (2011) Saffron: a potential target for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54(3):857–867
Zou P, Helson L, Maitra A, Stern ST, McNeil SE (2013) Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm 10(5):1977–1987. https://doi.org/10.1021/mp4000019
Bisht S, Mizuma M, Feldmann G, Ottenhof N, Hong SM, Pramanik D et al (2010) Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurcTM) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 9(8):2255–2264. https://doi.org/10.1158/1535-7163.MCT-10-0172
Chen D, Wan SB, Yang H, Yuan J, Chan TH (2011) Dou QP EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 53:155–177
Rahmani AH, Al shabrmi Fahad M, Allemailem KS, Aly SM, Khan MA (2015) Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway. Biomed Res Int 2015:925640
Fang C-Y, Wu C-C, Hsu H-Y, Chuang H-Y, Tsai C-H, Chen J-Y (2015) EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells. Int J Mol Sci 16(2):2530–2558
Larsen CA, Dashwood RH, Bisson WH (2010) Tea catechins as inhibitors of receptor tyrosine kinases: mechanistic insights and human relevance. Pharmacol Res 62(6):457–464
Khan N, Mukhtar H (2015) Dietary agents for prevention and treatment of lung cancer. Cancer Lett 359(2):155–164. https://doi.org/10.1016/j.canlet.2015.01.038
Yin OQ, Gallagher N, Li A et al (2010) Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants. J Clin Pharmacol 50(2):188–194
Rinella ES, Bankaitis ED, Threadgill DW (2012) Dietary calcium supplementation enhances efficacy but also toxicity of EGFR inhibitor therapy for colon cancer. Cancer Biol Ther 13(3):130–137. https://doi.org/10.4161/cbt.13.3.18690
Menéndez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R (2006) HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3) in breast cancer cells: the ‘fat features’ of the ‘Mediterranean diet’ as an ‘anti-HER2 cocktail. Clin Transl Oncol 8:812–820. https://doi.org/10.1007/s12094-006-0137-2
Sartippour MR, Pietras R, Marquez-Garban DC, Chen H-W, Heber D, Henning SM, Sartippour G, Zhang L, Ming L, Weinberg O, Rao JY, Brooks MN (December 2006) The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 27(12):2424–2433
Holmes FA, Liticker JD (2005) Pharmacogenomics of tamoxifen in a nutshell-and who broke the nutcracker? J Oncol Pract 1(4):155–159. https://doi.org/10.1200/JOP.2005.1.4.155
Hamaguchi R, Okamoto T, Sato M, Hasegawa M, Wada H (September 2017) Effects of an alkaline diet on EGFR-TKI therapy in EGFR mutation-positive NSCLC. Anticancer Res 37(9):5141–5151
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Flores-Pérez, J.A., de la Rosa Oliva, F., Argenes, Y., Meneses-Garcia, A. (2019). Nutrition, Cancer and Personalized Medicine. In: Ruiz-Garcia, E., Astudillo-de la Vega, H. (eds) Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics. Advances in Experimental Medicine and Biology, vol 1168. Springer, Cham. https://doi.org/10.1007/978-3-030-24100-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-24100-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24099-8
Online ISBN: 978-3-030-24100-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)